Physician profile
Emily F Mcgowin
NPI 1053829556
$408.44
in general payments reported to CMS, 2019-2025
13 companies · $33.18 in 2025
The $33.18 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.37 · 2022: $77.60 · 2023: $205 · 2024: $67.56 · 2025: $33.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $136.27 | 2022-2023 | Andexxa |
| Merck Sharp & Dohme LLC | $49.13 | 2022-2023 | Zerbaxa, Dificid, Recarbrio |
| Urgo Medical North America, LLC | $33.18 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Davol INC. | $32.51 | 2024 | Phasix Mesh |
| Kci USA, INC. | $27.42 | 2023 | Prevena, Abthera Advance, V.A.C.Ulta |
| Tela Bio, INC. | $21.67 | 2024 | Ovitex 2s |
| Mallinckrodt Hospital Products INC. | $18.90 | 2023 | Inomax |
| Convatec INC. | $18.46 | 2022 | |
| Shionogi INC | $18.29 | 2023 | Fetroja |
| Avanos Medical | $13.86 | 2022 | |
| Prytime Medical Devices, INC. | $13.38 | 2024 | Er-Reboa Plus |
| Teleflex LLC | $12.74 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Mcgowin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.